"Drug Name" "Drug Company" "IB Date" "Risk List Available?" Sutezolid "Global Alliance for TB Drug Development (TB Alliance)" "August, 2022" TBI-223 "Global Alliance for TB Drug Development (TB Alliance)" "August, 2022" "Bedaquiline (TMC207)" "Janssen Research & Development" "October, 2022" "Tecovirimat (TPOXX) - New" "SIGA Technologies, Inc." "January, 2024" "Pretomanid (PA-824)" "Global Alliance for TB Drug Development (TB Alliance)" "November, 2023" "Remdesivir (Veklury)" "Gilead Sciences" "June, 2021" Letermovir Merck "December, 2022" "Cenicriviroc Mesylate CVC (TBR-652)" Allergan "April, 2022" "Tenofovir Alafenamide/Elvitegravir" CONRAD "July, 2019" "Cemiplimab (REGN2810)" "Regeneron Pharmaceuticals, Inc." "September, 2021" "Sofosbuvir/Velapatasvir (Epclusa)" Gilead "July, 2016" "Vorinostat (Zolinza)" Merck "August, 2013" "ABT-267, ABT 333, ABT-450 and Ritonavir" AbbVie "June, 2017" "Dapivirine (Vaginal Ring) - New" "International Partnership For Microbicides" "November, 2022" "Delamanid (OPC-67683)" Otsuka "May, 2023" "Dolutegravir (GSK1349572)" "ViiV Healthcare" "October, 2023" "Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A)" Merck "July, 2021" "Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada)" "Gilead Sciences" "December, 2016" YES "GSK1265744 (Cabotegravir) - New" "ViiV Healthcare" "January, 2024" "Rilpivirine (TMC278, Edurant)" "Janssen Research & Development" "July, 2023"